Further studies are necessary to elucidate the underlying mechanism and subsequently to further establish TLR2 inhibition as a potential innovative therapeutic approach of reducing mortality and morbidity after cardiac arrest and cardiopulmonary resuscitation. This evidence concerns the gene TLR2 and cardiac arrest.